Breaking
XtalPi

XtalPi

Drug Discovery & Development

XtalPi is an AI drug discovery company leveraging artificial intelligence, quantum physics, and robotics to accelerate pharmaceutical research.

About XtalPi

XtalPi leverages AI, quantum physics, and automation to speed up drug discovery and materials research.

Mission & Approach

Mission

Our mission is to democratize access to data-driven discovery tools to accelerate the molecular R&D process.

AI Approach

AI generative molecular design, active learning for virtual screening, free energy perturbation (FEP) calculations, crystal structure prediction (CSP), physics-based modeling with quantum mechanics

Products & Solutions

XtalCSP

software

Crystal Structure Prediction software for polymorphic risk assessment

Cloud-based crystal structure prediction platform that performs global search of crystal structures to identify thermodynamically stable crystalline forms. Features intuitive user interface, scalable cloud resources, and ISO/IEC 27001:2013 compliant data security. Completes regular systems in 2-3 weeks and complex systems in 6-8 weeks.

Deploy: cloud saasPricing: undisclosed

ChemPlus

device

Desktop Solid Dispenser for automated powder dispensing

Desktop solid dispensing system for automated handling of solid materials in pharmaceutical research. Part of the autonomous laboratory infrastructure for enhanced precision and throughput in chemical execution.

Deploy: on premisePricing: undisclosed

XtalComplete

device

Intelligent Crystallization Workstation for automated solid-state research

Automated crystallization workstation for solid-state research and polymorph screening. Integrates with XtalPi's computational platforms to enable high-throughput experimental validation of predicted crystal forms.

Deploy: on premisePricing: undisclosed

NeoDispenser

device

Micro-Powder Dispensing System for precise material handling

Micro-powder dispensing system for precise automated handling of small quantities of solid materials in pharmaceutical research and development workflows.

Deploy: on premisePricing: undisclosed

PatSight

software

Patent Extraction tool for drug discovery intelligence

Digital chemistry platform tool that allows discovery scientists to extract patent data, supporting competitive intelligence and freedom-to-operate analysis in drug discovery projects.

Deploy: cloud saasPricing: undisclosed

PepiX

platform

Peptide Platform for peptide drug discovery

Specialized platform for peptide drug discovery combining AI and automation capabilities. Supports hit discovery and optimization for peptide-based therapeutics.

Deploy: cloud saasPricing: undisclosed

XmartChem

device

Intelligent Synthesis Workstation for automated chemical synthesis

Advanced automated system for chemical synthesis that streamlines experimental processes and increases efficiency and consistency of research activities. Part of the autonomous lab solution for digitized and automated chemistry execution at scale.

Deploy: on premisePricing: undisclosed

XFEP

Flagshipsoftware

High Accuracy Free Energy Calculation Tool for binding affinity predictions

Physics-based free energy perturbation technology for computationally predicting protein-ligand binding at an accuracy matching experimental methods. Covers drug design scenarios like binding free energy, scaffold hopping, and protein mutations across various targets with state-of-the-art molecular force field.

Deploy: cloud saasPricing: undisclosed

XtalGazer

Flagshipplatform

Solid State Research Solution for polymorph screening and crystallization

Comprehensive solid-state research platform combining computational chemistry and AI to empower pharmaceutical solid-state research. Includes crystal structure prediction (CSP), solid-state virtual screening, and morphology prediction capabilities for polymorphic risk assessment and stability analysis.

Deploy: cloud saasPricing: undisclosed

XMolGen

Flagshipsoftware

Generative Chemistry Tool for AI-driven molecular design

AI compound generation platform that enables exploration of ultra-large chemical space. Covers most molecular design scenarios and generation strategies, allowing discovery scientists to explore novel chemical space and quickly identify promising drug candidates.

Deploy: cloud saasPricing: undisclosed

Customer Success Stories

Undisclosed research partner

pharma

SARM1 mechanism of action demonstration

First-ever demonstration of SARM1's mechanism of action using Cryo-EM
Read case study →

Undisclosed pharmaceutical partner

pharma

Novel hit discovery against GPX4 target

Discovered novel, non-covalent, potent hits against GPX4 in 28 days
Read case study →

Multiple pharmaceutical partners

pharma

Polymorphic risk assessment using crystal structure prediction

Derisked more than 300 systems since 2017 with all crystalline forms obtained by experiments covered in CSP studies
Read case study →

Hiring Activity

View Open Roles →

Product & Market

Product Stage

launched

Primary Market

pharma

Company Details

Founded
2015
Headquarters
Cambridge, MA, USA
Employees
1254
Stage
public
Profile last updated
June 22, 2026

Work here?

Claim this listing to update company information and connect with our audience.

Claim This Listing

Social & Media

Follow on

Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as employee counts and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.